Rui L - Search Results

1

A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell development.

Gosling KM, Makaroff LE, Theodoratos A, Kim YH, Whittle B, Rui L, Wu H, Hong NA, Kennedy GC, Fritz JA, Yates AL, Goodnow CC, Fahrer AM. Gosling KM, et al. Among authors: rui l. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12445-50. doi: 10.1073/pnas.0704870104. Epub 2007 Jul 17. Proc Natl Acad Sci U S A. 2007. PMID: 17640884 Free PMC article.

2

Lymphoma and the control of B cell growth and differentiation.

Rui L, Goodnow CC. Rui L, et al. Curr Mol Med. 2006 May;6(3):291-308. doi: 10.2174/156652406776894563. Curr Mol Med. 2006. PMID: 16712476 Review.

3

Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.

Rui L, Vinuesa CG, Blasioli J, Goodnow CC. Rui L, et al. Nat Immunol. 2003 Jun;4(6):594-600. doi: 10.1038/ni924. Epub 2003 May 11. Nat Immunol. 2003. PMID: 12740574

4

A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, Roberts IS, Copley RR, Bell JI, Cornall RJ, Goodnow CC. Vinuesa CG, et al. Among authors: rui l. Nature. 2005 May 26;435(7041):452-8. doi: 10.1038/nature03555. Nature. 2005. PMID: 15917799

5

ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation.

Rui L, Healy JI, Blasioli J, Goodnow CC. Rui L, et al. J Immunol. 2006 Oct 15;177(8):5337-46. doi: 10.4049/jimmunol.177.8.5337. J Immunol. 2006. PMID: 17015719

6

Tolerance mechanisms in the late phase of the antibody response.

Goodnow CC, Campbell JA, Rui L, Vinuesa CG. Goodnow CC, et al. Among authors: rui l. Adv Exp Med Biol. 2007;596:163-8. doi: 10.1007/0-387-46530-8_15. Adv Exp Med Biol. 2007. PMID: 17338185 Review. No abstract available.

7

Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice.

Masle-Farquhar E, Russell A, Li Y, Zhu F, Rui L, Brink R, Goodnow CC. Masle-Farquhar E, et al. Among authors: rui l. PLoS One. 2021 Apr 29;16(4):e0237830. doi: 10.1371/journal.pone.0237830. eCollection 2021. PLoS One. 2021. PMID: 33914737 Free PMC article.

8

Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.

Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM. Hodson DJ, et al. Among authors: rui l. Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2039-46. doi: 10.1073/pnas.1600557113. Epub 2016 Mar 18. Proc Natl Acad Sci U S A. 2016. PMID: 26993806 Free PMC article.

9

Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.

Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM. Chiorazzi M, et al. Among authors: rui l. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3943-8. doi: 10.1073/pnas.1217271110. Epub 2013 Feb 19. Proc Natl Acad Sci U S A. 2013. PMID: 23431138 Free PMC article.

10

STAT3 Activation and Oncogenesis in Lymphoma.

Zhu F, Wang KB, Rui L. Zhu F, et al. Among authors: rui l. Cancers (Basel). 2019 Dec 19;12(1):19. doi: 10.3390/cancers12010019. Cancers (Basel). 2019. PMID: 31861597 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page